El-Kamel AH - Search Results

1

Engineering tanshinone-loaded, levan-biofunctionalized polycaprolactone nanofibers for treatment of skin cancer.

El-Habashy SE, El-Kamel AH, Mehanna RA, Abdel-Bary A, Heikal L. El-Habashy SE, et al. Among authors: el kamel ah. Int J Pharm. 2023 Oct 15;645:123397. doi: 10.1016/j.ijpharm.2023.123397. Epub 2023 Sep 9. Int J Pharm. 2023. PMID: 37690657

2

Helicobacter pylori: an overview on antimicrobials and drug delivery systems for its eradication.

El-Zahaby SA, Kassem AA, El-Kamel AH. El-Zahaby SA, et al. Curr Drug Deliv. 2014;11(3):306-12. doi: 10.2174/1567201811666140327145049. Curr Drug Deliv. 2014. PMID: 24678600 Review.

3

Formulation and in vitro evaluation of size expanding gastro-retentive systems of levofloxacin hemihydrate.

El-Zahaby SA, Kassem AA, El-Kamel AH. El-Zahaby SA, et al. Int J Pharm. 2014 Apr 10;464(1-2):10-8. doi: 10.1016/j.ijpharm.2014.01.024. Epub 2014 Jan 26. Int J Pharm. 2014. PMID: 24472642

4

Novel treatment strategies for brain tumors and metastases.

El-Habashy SE, Nazief AM, Adkins CE, Wen MM, El-Kamel AH, Hamdan AM, Hanafy AS, Terrell TO, Mohammad AS, Lockman PR, Nounou MI. El-Habashy SE, et al. Pharm Pat Anal. 2014 May;3(3):279-96. doi: 10.4155/ppa.14.19. Pharm Pat Anal. 2014. PMID: 24998288 Free PMC article. Review.

5

Effect of sterilization on the physical stability of brimonidine-loaded solid lipid nanoparticles and nanostructured lipid carriers.

El-Salamouni NS, Farid RM, El-Kamel AH, El-Gamal SS. El-Salamouni NS, et al. Int J Pharm. 2015 Dec 30;496(2):976-83. doi: 10.1016/j.ijpharm.2015.10.043. Epub 2015 Oct 21. Int J Pharm. 2015. PMID: 26498372

6

Ethyl cellulose nanoparticles as a platform to decrease ulcerogenic potential of piroxicam: formulation and in vitro/in vivo evaluation.

El-Habashy SE, Allam AN, El-Kamel AH. El-Habashy SE, et al. Int J Nanomedicine. 2016 May 26;11:2369-80. doi: 10.2147/IJN.S93354. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27307735 Free PMC article.

7

Mucopenetrating nanoparticles for enhancement of oral bioavailability of furosemide: In vitro and in vivo evaluation/sub-acute toxicity study.

Radwan SE, Sokar MS, Abdelmonsif DA, El-Kamel AH. Radwan SE, et al. Int J Pharm. 2017 Jun 30;526(1-2):366-379. doi: 10.1016/j.ijpharm.2017.04.072. Epub 2017 May 6. Int J Pharm. 2017. PMID: 28487189

8

Enhanced oral bioavailability of Tanshinone IIA using lipid nanocapsules: Formulation, in-vitro appraisal and pharmacokinetics.

Ashour AA, Ramadan AA, Abdelmonsif DA, El-Kamel AH. Ashour AA, et al. Int J Pharm. 2020 Aug 30;586:119598. doi: 10.1016/j.ijpharm.2020.119598. Epub 2020 Jul 3. Int J Pharm. 2020. PMID: 32629068

9

Hybrid bioactive hydroxyapatite/polycaprolactone nanoparticles for enhanced osteogenesis.

El-Habashy SE, Eltaher HM, Gaballah A, Zaki EI, Mehanna RA, El-Kamel AH. El-Habashy SE, et al. Mater Sci Eng C Mater Biol Appl. 2021 Feb;119:111599. doi: 10.1016/j.msec.2020.111599. Epub 2020 Oct 8. Mater Sci Eng C Mater Biol Appl. 2021. PMID: 33321643

10

Biomaterial-Based Nanocomposite for Osteogenic Repurposing of Doxycycline.

El-Habashy S, Eltaher H, Gaballah A, Mehanna R, El-Kamel AH. El-Habashy S, et al. Int J Nanomedicine. 2021 Feb 12;16:1103-1126. doi: 10.2147/IJN.S298297. eCollection 2021. Int J Nanomedicine. 2021. PMID: 33603371 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page